✦ LIBER ✦

Ceramide metabolism in brain

✍ Scribed by Yasuo Kishimoto; Nariko Kawamura

Book ID: 104672283
Publisher: Springer
Year: 1979
Tongue: English
Weight: 676 KB
Volume: 23
Category: Article
ISSN: 0300-8177
DOI: 10.1007/bf00226676

No coin nor oath required. For personal study only.

✦ Synopsis

Ceramide is the fundamental structure and key intermediate of all sphingolipids. Biosynthesis and catabolism of brain ceramide, especially their relationship to the metabolism of more complex sphingolipids in brain, are reviewed. Human genetic diseases which involve altered ceramide metabolism are also discussed.

📜 SIMILAR VOLUMES

Ceramide hexosides in niemann-pick disea

Ceramide hexosides in niemann-pick disease brain

✍ Mark Greenbaum; Linda M. Hoffman; Larry Schneck 📂 Article 📅 1976 🏛 Springer 🌐 English ⚖ 397 KB

Ceramide 1-Phosphate Phosphatase Activit

Ceramide 1-Phosphate Phosphatase Activity in Brain

✍ Rajesh Shinghal; Richard H. Scheller; Sandra M. Bajjalieh 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 870 KB

Brain Metabolism

✍ MCILWAIN, H. 📂 Article 📅 1973 🏛 Nature Publishing Group 🌐 English ⚖ 267 KB

Metabolic Formation of Ceramide-1-Phosph

Metabolic Formation of Ceramide-1-Phosphate in Cerebellar Granule Cells: Evidence for the Phosphorylation of Ceramide by Different Metabolic Pathways

✍ Laura Riboni; Rosaria Bassi; Viviana Anelli; Paola Viani 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 236 KB

Perturbation of sphingolipid metabolism

Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia

✍ Norman J. Haughey; Roy G. Cutler; Anita Tamara; Justin C. McArthur; Diana L. Var 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 732 KB

Ceramide metabolism determines glioma ce

Ceramide metabolism determines glioma cell resistance to chemotherapy

✍ Claudia Alexandra Dumitru; Michael Weller; Erich Gulbins 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

## Abstract Tumor cell resistance to chemotherapy constitutes a major problem in the treatment of malignant tumors. We here investigated the role of ceramide metabolism for the resistance of glioma cells to treatment with the chemotherapeutic drug, gemcitabine. Gemcitabine triggers a marked release